Aspire Biopharma (ASBP) Holdings announced a strategic initiative to rapidly increase the production capacity of its BUZZ BOMB single dose caffeine pre-workout supplement through a new manufacturing relationship with SupraNaturals. As part of this agreement, Aspire Biopharma announced an initial production order of two million servings of BUZZ BOMB pre-workout supplement, marking a significant milestone in the Company’s expansion efforts.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASBP: